Interaction of purified ribonucleic acid directed deoxyribonucleic acid polymerase of avian myeloblastosis virus and murine sarcoma-leukemia virus with a rifamycin SV derivative.
D000494:Allosteric Regulation; D001354:Avian Leukosis Virus / Q000201:enzymology*; D001593:Benzyl Compounds / Q000378:metabolism / Q000494:pharmacology; D001665:Binding Sites; D004247:DNA / Q000096:biosynthesis; D003854:Deoxyribonucleotides / Q000378:metabolism / Q000494:pharmacology; D004926:Escherichia coli / Q000201:enzymology; D007700:Kinetics; D008970:Molecular Weight; D008979:Moloney murine leukemia virus / Q000201:enzymology*; D011119:Polynucleotides / Q000494:pharmacology; D011485:Protein Binding; D012313:RNA; D012194:RNA-Directed DNA Polymerase / Q000302:isolation & purification; D018894:Reverse Transcriptase Inhibitors; D012294:Rifamycins / Q000378:metabolism* / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013698:Templates, Genetic; D014316:Tritium
D001593:Benzyl Compounds; D003854:Deoxyribonucleotides; D011119:Polynucleotides; D018894:Reverse Transcriptase Inhibitors; D012294:Rifamycins; D014316:Tritium; D012313:RNA; D004247:DNA; D012194:RNA-Directed DNA Polymerase